CAMP Q2 2022 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M-18.8% YoY

Gross Profit

$26M39.6% margin

Operating Income

-$9M-14.4% margin

Net Income

-$12M-18.8% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-5.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$375M

Total Liabilities

$346M

Stockholders' Equity

$29M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$80M	-18.8%
Gross Profit	$26M	$32M	-21.0%
Operating Income	-$9M	-$1M	-658.9%
Net Income	-$12M	-$2M	-524.9%

Revenue Segments

Product

$39M61%

Application Subscriptions And Other Services

$25M39%

Geographic Segments

UNITED STATES

$40M62%

E M E A

$13M19%

Latin America

$6M9%

Asia Pacific

$5M8%

All Other

$589,0001%